Markets
-
Springer-Peterson Roofing Joins Roofing Corp of America
Roofing Corp of America (RCA) acquired Springer-Peterson Roofing & Sheet Metal, marking its 15th acquisition. Springer-Peterson, a leading commercial and industrial roofing contractor in central Florida since 1981, will operate as a stand-alone entity within RCA. This partnership expands RCA’s footprint in Florida, enhancing its services and market reach. Springer-Peterson’s leadership will remain in place. The acquisition aligns with RCA’s vision to consolidate the roofing industry by integrating premier contractors and leveraging economies of scale, backed by FirstService Corporation.
-
Yan Chuang Dumps Xiaomi Car, Cites Values Clash
A prominent automotive blogger, Yan Chuang, publicly distanced himself from Xiaomi’s YU7 electric vehicle, citing concerns over build quality issues like rattling noises. He also criticized Xiaomi’s lack of transparency regarding quality concerns, including reported problems with the carbon fiber hood and autonomous driving systems. The controversy has sparked debate, with some praising his advocacy for consumer rights, while others question his motives. This incident underscores the challenges Xiaomi faces in the automotive market, highlighting the need for robust quality control and transparent communication to maintain consumer trust.
-
CleanCore Solutions Appoints New CIO, Announces Robinhood Partnership (NYSE American:ZONE)
CleanCore Solutions (ZONE) appointed Marco Margiotta as CIO and partnered with Robinhood. The company secured over 500 million Doge towards its 1 billion target. Fiscal 2024 revenue grew 29% to $2.07 million, with U.S. quarterly sales exceeding $1 million for the first time. CleanCore acquired Sanzonate Europe, gained GSA contractor approval, and landed a major contract with a global logistics provider covering over 1,000 facilities. CleanCore is pioneering a modern treasury model alongside innovation in clean technology.
-
Green Rain Energy Holdings (GREH) Anticipates October Groundbreaking for Rochester, NY EV Project
Green Rain Energy Holdings Inc. (OTC:GREH) plans to begin construction on a Level 3 EV charging station in Rochester, NY, by October 2025. The project, located at 1600 W Ridge Road, has received permit approval. It will integrate solar power, green retrofit technology, and next-generation storage systems. A special dividend for shareholders is scheduled for October 28th, pending FINRA approval. While the project promises positives, specific timelines,costs and funding sources remain undisclosed.
-
XiBei Reveals Luo Yonghao’s Restaurant Bill: 15 Dishes Cost 830 Yuan
A dispute arose in China after Luo Yonghao criticized Xibei restaurant chain for allegedly using pre-prepared meals. Xibei’s founder, Jia Guolong, denied the claim and threatened legal action, releasing Luo’s bill to justify pricing. Online debate ensued regarding Xibei’s prices. Xibei launched a “Luo Yonghao Menu,” offered a money-back guarantee, and invited customers to observe meal preparation, emphasizing transparency. This incident underscores increasing consumer scrutiny in the food industry and the impact of social media.
-
Toll Brothers Expands Shavano Highlands Community in San Antonio with New Phase of Home Sites
Toll Brothers (NYSE:TOL) is opening a new phase of luxury single-family homes in San Antonio’s Shavano Highlands. Homes on 90-foot-wide lots range from 3,198 to over 5,184 square feet, with 4-5 bedrooms, 3.5-6.5 bathrooms, and 3-4 car garages. Prices start at $1 million. The gated community offers access to Salado Creek Greenway trails and is served by the Northside Independent School District. The high price point might limit the buyer pool.
-
HII Boosts Throughput, Expands Industrial Base with Distributed Shipbuilding
HII is expanding shipbuilding capacity via strategic partnerships and distributed manufacturing. Outsourced hours doubled in 2025, aiming to quadruple within two years. A structural assembly network includes 23 partners, growing further. Key moves include acquiring a Goose Creek facility for submarine and aircraft carrier modules, partnerships with six shipbuilders for Arleigh Burke-class destroyers, and international collaborations with Hyundai Heavy Industries and Babcock International Group to enhance production efficiency and strengthen the industrial base.
-
Jia Guolong to Sue Luo Yonghao; Luo Yonghao Responds with Evidence
A public dispute erupted in China between influencer Luo Yonghao and Xibei restaurant founder Jia Guolong over Xibei’s use of pre-made dishes. Luo criticized Xibei’s practices on social media, prompting a strong response from Jia and a heated debate about food preparation transparency. Xibei responded by launching a “Luo Yonghao Menu” with a satisfaction guarantee and inviting customers to observe dish preparation. The controversy highlights the pressure on Chinese restaurants to balance efficiency with consumer demands for fresh ingredients and transparency.
-
Planet Announces Speakers for “On the Road” Berlin Event
Planet Labs Germany is hosting “Planet On The Road” in Berlin on September 24, 2025, bringing together Earth observation leaders. The event features keynotes, panels, and discussions on leveraging satellite technology and data analytics across sectors like agriculture, disaster response, and finance. Speakers from Planet, Bayer, DLTR, and other organizations will address challenges and opportunities in EMEA. Sessions will cover the EU Space Act, AI applications, and innovative uses of Planet’s high-frequency imagery. Registration is open until September 17, 2025..
-
Seaport Therapeutics Advances GlyphAgo™ (SPT-320) to Phase 1 with First Healthy Volunteer Dosed
Seaport Therapeutics initiated a Phase 1 trial for GlyphAgo (SPT-320), an oral prodrug of agomelatine, targeting Generalized Anxiety Disorder (GAD). GlyphAgo utilizes the Glyph™ technology to enhance agomelatine’s bioavailability by promoting lymphatic absorption, bypassing first-pass liver metabolism. The study will assess safety, tolerability, and pharmacokinetics, aiming to achieve therapeutic agomelatine levels at lower doses to reduce liver exposure. This marks Seaport’s second therapeutic candidate entering clinical development.